baber/WOPTO huggingface dataset:
Patent NZ-520724-A (NZ)
Title: Tetrahydro-pyridine compounds for inhibiting neuraminidase and treating influenza neuraminidase
Inventor: BISCHOFBERGER NORBERT W
IPC: A61K31/4015
Filed: 1996-02-26
Abstract: A compound of formula (I) or (II) or the salts, solvates, resolved enantiomers and purified diastereomers thereof is used to inhibit the activity of neuroaminidase or for treating or the prophylaxis of an virus infection in a nonhuman host wherein: A1 is -C(J1)= or -N=; A2 is-C(J1)2-, -N(J1)-, -N(O)(J1)-, -N(O)=, -S-, -S(O)-, - S(O)2- or -O-; E1 is -(CR1R1)m1W1; G1 is N3, CN, -OH, -OR6a -NO2, or -(CR1R1)m1W2; T1 is -NR1W3, a heterocycle, or is taken together with U1 or G1 to form a group of formula (III) U1 is H or -X1W6; J1 and J1a are independently R1, Br, Cl, F, I, CN, NO2 or N3; J2 and J2a are independently H or R1; R1 is independently H or alkyl; R2 is independently R3 or R4 wherein each R4 is independently substituted with 0 to 3 R3 groups; R3 is independently F, Cl, Br, I, -CN, N3, -NO2, -OR6a, - OR1, -N(R1)2, -N(R1)(R6b), -N(R6b)2, -SR1, -SR6a, -S(O)R1, -S(O)2R1, -S(O)OR1, -S(O)OR6a, -S(O)2OR1, -S(O)2OR6a, - C(O)OR1, -C(O)R6c, -C(O)OR6a, -OC(O)R1, -N(R1)(C(O)R1), - N(R6b)(C(O)R1), -N(R1)(C(O)OR1), -N(R6b)(C(O)OR1), - C(O)N(R1)2, -C(O)N(R6b)(R1), -C(O)N(R6b)2, -C(NR1)(N(R1)2), -C(N(R6b))(N(R1)2), -C(N(R1))(N(R1)(R6b)), - C(N(R6b))(N(R1)(R6b)), -C(N(R1))(N(R6b)2), - C(N(R6b))(N(R6b)2), -N(R1)C(N(R1))(N(R1)2), - N(R1)C(N(R1))(N(R1)(R6b)), -N(R1)C(N(R6b))(N(R1)2), - N(R6b)C(N(R1))(N(R1)2), -N(R6b)C(N(R6b))(N(R1)2), - N(R6b)C(N(R1))(N(R1)(R6b)), -N(R1)C(N(6b))(N(R1)(R6b)), - N(R1)C(N(R1))(N(R6b)2), -N(R6b)C(N(R6b))(N(R1)(R6b)), - N(R6b)C(N(R1))(N(R6b)2) -N(R1)C(N(R6b))(N(R6b)2), - N(R6b)C(N(R6b))(N(R6b)2), =0, =S, =N(R1) or =N(R6b); R4 is independently alkyl, alkenyl, or alkynyl; R5 is independently R4 wherein each R4 is substituted with 0- 3 R3 groups; R5a is independently alkylene, alkenylene, or alkynylene all of which may be substituted with 0-3 R3 groups; R6a is independently H or an ether- or ester-forming group; R6b is independently H, a protecting group for amino or the residue of a carboxyl-containing compound; R6c is independently H or the residue of an amino-containing compound; W1 is a group comprising an acidic hydrogen, a protected acidic group, or an R6c amide of the group comprising an acidic hydrogen; W2 is a group comprising a basic heteroatom or a protected basic heteroatom, or an R6b amide of the basic heteroatom; W3 is W4 or W5; W4 is R5 or -C(O)R5, -C(O)W5, -SO2R5, or -SO2W5; W5 is carbocycle or heterocycle wherein W5 is independently substituted with 0 to 3 R2 groups; W6 is -R5, -W5, -R5aW5, -C(O)OR6a, -C(O)R6c, -C(O)N(R6b)2, - C(NR6b)(N(R6b)2), -C(NR6b)(N(H)(R6b)), -C(N(H)(N(R6b)2), - C(S)N(R6b)2, -C(O)R2, -(CH2)m1C((CH2)m3R5aW5)3, - (CH2)m1C((CH2)m3R3)((CH2)m3R5aW5)2, where m3 is 1-3; X1 is a bond, -O-, -N(H)-, -N(W6)-, -N(OH)-, -N(OW6)-, - N(NH2)-, -N(N(H)(W6))-, -N(N(W6)2)-, -N(H)N(W6)-, -S-, -SO- , or -SO2-; and m1 is independently 0 to 2; limited by the provisos as defined in the specification.
Patent NZ-525812-A (NZ)
Title: Supplement to be enterally administered for parenteral nutrition or partial enteral/oral nutrition of the critically ill, the chronically ill and people with malnutrition
Inventor: RIEDEL ANGELIKA
IPC: A23L33/15
Filed: 2001-11-14
Abstract: A supplement to be administered enterally to maintain or restore the intestinal barrier of the critically or chronically ill and people with malnutrition, characterised in that it has a total energy content per daily dose of up to 4185kJ and comprises as solution: a) glutamine and/or glutamine precursors in an amount in the range from 15 to 70g, where in the case of glutamine precursors the stated amounts are based on the glutamine content thereof; b) at least two representatives from the group of substances having antioxidant activity selected from the group consisting of vitamins, amino acids, amino acid derivatives, amino sulfonic acid, trace elements, polyphenols and carotenoids; and c) short chain fatty acids or precursors thereof having in an amount of from 0.5g to 10g where in the case of precursors the stated amounts are based on the short-chain fatty acid content thereof. Also disclosed is the use of components (a)-(c) in the preparation of said supplement.
Patent NZ-529368-A (NZ)
Title: Benzamidoacetonitriles and their use as antiparasitics
Inventor: DUCRAY PIERRE
IPC: C07C323/42
Filed: 2002-05-14
Abstract: Benzamidoacetonitrile compounds of the formula (I) and enantioners thereof are disclosed, wherein R3, R4, R5, R6, R7, R8, Ar2, Q1, Q2, a, b and n are as defined in the specification. These compounds as active ingredients have pesticidal properties. They are especially suitable for controlling parasites in warm-blooded animals.
Patent NZ-529903-A (NZ)
Title: Novel substituted 1,3-propadiamides as cathepsin inhibitors
Inventor: PATTERSON JOHN W
IPC: A61K31/44
Filed: 2002-06-04
Abstract: Described is a compound of formula I as well as the N-oxide derivatives, prodrug derivatives, protected derivatives, individual isomers and mixtures of isomers thereof; and the pharmaceutically acceptable salts and solvates of such compounds. X1 is -NHC(R1)(R2)X2; X2 is cyano,-C(R7)R8X3; R6 is hydrogen or (C1-6) alkyl; R7 and R8 together form oxo; X3 comprises a heteromonocyclic ring containing 4 to 6 ring member atoms or a fused heterobicyclic ring system containing 8 to 14 ring member atoms and any carbocyclic ketone, iminoketone or thioketone derivative thereof; X4 is a bond or (C1-6)alkyl; R12 at each occurrence independently is hydrogen, (C1-6) alkyl and R14 is (C 3-10) cycloalkyl (C0-6)alkyl, hetero(C3-10)cycloalkyl(C0-3)alkyl, (C6-10) aryl(C0-6)alkyl, hetero(C5-10)aryl(C0-6)alkyl, (C9-10)bicycloaryl(C0-6)alkyl or hetero(C8-10) bicycloaryl(C0-6)alkyl; R1 is hydrogen; and R2 is hydrogen; R3 is -C(R6)(R6)X5, wherein R6 is as defined above and X5 is selected from -X4R12, -R14, -X4SR14, -X4S(O)2R14 wherein X4 R12 and R14 are as defined above; R4 is -NR6R6, -NR6R14, -NR6R15 or -NR6X5C(O)R14 wherein R6, X5 and R14 are as described above and R15 is hydrogen, -(C1-6) alkyl; wherein within R3 and R4 any alicyclic or aromatic ring system may be substituted further by nitro, -X4OR12, -X4C(O)NR12R12, -X4OR14, and within R3 and R4 any aliphatic moiety may be substituted further by cyano. The compound is described to be used in a pharmaceutical composition to inhibit Cathepsin S, for the treatment of diseases such as arthritis, muscular dystrophy, inflammation, malaria and periodontal disease.
Patent NZ-543784-A (NZ)
Title: Sampling device to assemble tissue array
Inventor: CHAUMAT PIERRE
IPC: C12M1/26
Filed: 2005-11-24
Abstract: A core sampling device (1) intended to assemble tissue arrays of the type incorporating a core sampling punch (5), a core excision punch (6) intended to make recesses in one or several so-called receiver blocks, and means (7) to expel the sample cores into one or several paraffin receiver blocks (9, 10) or into any frozen milieu or not, characterized by the fact that the core excision punch (6) is mounted substantially coaxially in the core sampling punch (5), the sampling punch being in the external position, both punches (5, 6) being able to move in translation and/or rotation with respect to one another, and the ejection means being arranged to as to expel the cores from each punch.
Patent NZ-544757-A (NZ)
Title: Air handling heat exchanger humidifying apparatus
Inventor: NORTH GARY MARTIN
Filed: 2006-01-18
Abstract: An air handling heat exchanger humidifying apparatus (1) is provided with a humidifying cell (13) of a self supporting sheet like body with closely spaced air openings therein. Air is moved through the apparatus (1) so it passes through the openings in the humidifying cell (13). A humidifying liquid is deposited onto the body surfaces of the cell between adjacent openings. As the air moves through the openings it collects the humidifying liquid from the surfaces of the cell (13). The humidifying liquid can be cooled. The air then exits the apparatus (1) and can be used for cooling produce or other product. The cell (13) can be an expanded mesh with the openings having a somewhat diamond shape. The cell (13) body can be corrugated to assist in humidifying liquid retention.
Patent NZ-547382-A (NZ)
Title: Oxazolidinone-quinolone hybrid antibiotics
Inventor: HUBSCHWERLEN CHRISTIAN
IPC: C07D413/14
Filed: 2004-12-20
Abstract: Disclosed is a compound of formula (I), or a pharmalogically acceptable salt, solvate, hydrate, or formulation thereof, wherein Q is CR4, R4 is hydroxy, a group of formula OPO3R92 or OSO3R10 or a heteroalkyl group carrying at least one OH, NH2, SO3R10, PO3R92 or COOH group or an ester of a naturally occurring amino acid or a derivative thereof, R5 is a ring containing oxygen and optionally nitrogen selected from the options described in the specification, X is CR7 or N, Y is CR6 or N, m and n are each between 1 and 3, R2 is H, F, or Cl, and wherein the other substituents are as described in the specification. Also disclosed is the use of the compound for treating bacterial infections.
Patent NZ-553625-A (NZ)
Title: Antibody formulation in histidine-acetate buffer
Inventor: ANDYA JAMES D
IPC: A61K39/395
Filed: 2005-10-19
Abstract: Disclosed is a stable pharmaceutical formulation comprising a monoclonal antibody in histidine acetate buffer, pH 5.5 to 6.5, wherein the monoclonal antibody is susceptible to deamidation and aggregation.
Patent NZ-553721-A (NZ)
Title: Method of manufacturing bismuth-based oxide superconductor and superconducting wire
Inventor: AYAI NAOKI
IPC: C01G29/00
Filed: 2006-03-09
Abstract: Disclosed is a method of manufacturing a bismuth-based oxide superconductor containing a 2223 phase having a 2223 composition in a composition Bi-Sr-Ca-Cu or (Bi,Pb)-Sr-Ca-Cu, comprising a first step of charging a raw material containing a 2212 phase having a 2212 composition in the composition Bi-Sr-Ca-Cu or (Bi,Pb)-Sr-Ca-Cu with a critical temperature of not more than 70 K into a metal sheath, a second step of performing plastic working on said metal sheath charged with said raw material and a third step of performing heat treatment on said metal sheath charged with said raw material. Also disclosed is a superconducting wire containing a bismuth-based oxide superconductor manufactured by the above method..
Patent NZ-556202-A (NZ)
Title: Cooling topical patch preparation
Inventor: SHUDO JUTARO
IPC: A61F13/00
Filed: 2005-12-16
Abstract: Disclosed is a topical patch preparation comprising: an adhesive gel composition comprising a water-soluble polymer gel, water and a water holding agent and a physiological cooling agent as the only active agent in said adhesive gel composition wherein said agent is odourless (meaning that the odor of said agent is less pungent than the odor of menthol); and a support. Particularly suitable physiological cooling agents include an acyclic amide such as N,2,3-Trimethyl-2-isopropylbutanamide. These topical patches are suitable for applying to a skin surface for treating inflammation or pain, wherein the topical patch preparations are applied to a skin surface of a subject and maintained at the site of application for a period of time sufficient for an effective amount of the an odorless physiological cooling agent to be administered to the subject.
Patent NZ-556670-A (NZ)
Title: Loging into a wireless network from external device using public/private keys exchanged over a short distance
Inventor: LEE SUNG-MIN
IPC: H04L9/30
Filed: 2006-02-03
Abstract: A wireless network system and a communication method, where an external network device (150) easily and temporarily logs in and out of the wireless network (100). A key management device of the wireless network system includes a limited communication unit that receives encryption information from a wireless network device, a storage unit that stores authentication information for authenticating the wireless network device, and a key creating unit that creates an encryption key using the received encryption information to allow the wireless network device to log onto the wireless network. The key creating unit also transmits the created encryption key to the wireless network device.
Patent NZ-560293-A (NZ)
Title: Protective glove
Inventor: BRADLEY ROGER ROBERT ANDREW
Filed: 2007-08-02
Abstract: This discloses a glove comprising: an inner glove 3 for receiving a user's hand and having finger portions with reverse surfaces; and protective padding 15 extending over at least a portion of the reverse surfaces of the finger portions; wherein the protective padding is attached to the inner glove 3 at discrete locations such that when the finger portions extend from a flexed position some of the protective padding moves away from the reverse surfaces of the finger portions of the inner glove to create or enlarge air passages between the protective padding and the reverse surfaces.
Patent NZ-563563-A (NZ)
Title: Crystalline form of 1-chloro-4-(beta-D-glucopyranos-1-yl)-2-[4-((S)-tetrahydrofuran-3-yloxy)-benzyl]-benzene, a method for its preparation and the use thereof for preparing medicaments
Inventor: ECKHARDT MATTHIAS
IPC: A61K31/351
Filed: 2006-05-02
Abstract: Disclosed is a crystalline form of 1-chloro-4-(beta-D-glucopyranos-1-yl)-2-[4-((S)-tetrahydrofuran-3-yloxy)-benzyl]-benzene, the compound of formula A, having an X-ray powder diffraction pattern that comprises peaks at 18.84, 20.36 and 25.21 degrees 2theta. Also disclosed is a method of preparing the crystalline form. Also disclosed is the use of the form for inhibiting the sodium-dependent glucose cotransporter SGLT. Also disclosed is the use of the form for treating metabolic disorders such as diabetes, metabolic acidosis or ketosis, reactive hypoglycaemia, hyperinsulinaemia, glucose metabolic disorder, insulin resistance, metabolic syndrome, dyslipidaemias, atherosclerosis, obesity, high blood pressure, chronic heart failure, oedema, and hyperuricaemia.
Patent NZ-570894-A (NZ)
Title: Linear stalk separator with alternating oscillating movements
Inventor: PELLENC ROGER
Filed: 2008-08-29
Abstract: A stalk separator for the de-stalking of small fruit picked in bunches is disclosed. The stalk separator includes a conveyor belt 1 and a de-stalking device which is positioned above the conveyor belt. The de-stalking device includes at least two berry-detaching assemblies 6A, 6B positioned opposite each other and separated by a vertical space. The berry-detaching assemblies include a number of stacked separator arms 6, and at least one drive 3 to communicate a high frequency oscillating movement through the assemblies.
Patent NZ-577166-A (NZ)
Title: Method of treating autoimmune disease by inducing antigen presentation by tolerance inducing antigen presenting cells
Inventor: BOWDISH KATHERINE S
IPC: A61K/
Filed: 2004-03-04
Abstract: Provided is an antibody/peptide construct comprising a monoclonal antibody to human DCSIGNR linked to a peptide, wherein the peptide is an autoantigen, further wherein said antibody interferes with the interaction of DC-SIGNR expressing cells and ICAM-expressing cells. The construct can be used in a vaccine or linked to a tumour cell toxin.
Patent NZ-579693-A (NZ)
Title: System and method for driving and receiving data from multiple touch screen devices
Inventor: ALLEN JAMES F
IPC: G06F3/14
Filed: 2008-03-10
Abstract: Disclosed is an apparatus for driving a plurality of touch screen devices from a single graphics signal. The apparatus includes a general-purpose computer configured to provide a graphics signal of a particular display resolution. The graphics signal has a plurality of graphics frames. The apparatus also includes a display segmentor configured to divide a first portion of each graphics frame into a plurality of pixel groups, while a second portion of each graphics frame is not a part of any pixel group of the plurality of pixel groups. Each pixel group is associated with a particular touch screen device of the plurality of touch screen devices. The display segmentor is further configured to generate an individual graphics signal for each pixel group. Each individual graphics signal has a display resolution that is lower than the particular display resolution. The apparatus further includes one or more interfaces configured to transmit each individual graphics signal to one of the plurality of touch screen devices.
Patent NZ-584882-A (NZ)
Title: Drive for transit door
Inventor: HEIDRICH PETER
IPC: B60J5/06
Filed: 2008-07-24
Abstract: Disclosed is a multi-part drive shaft for a transit vehicle door. The drive shaft comprises an upper drive shaft connected to a door operating mechanism and having a door panel operating arm extending from it, a lower drive shaft journaled for rotation, with a door panel operating arm extending from it, and a flexible drive shaft secured at one end to the upper drive shaft and at the other end to the lower drive shaft. Rotation of the upper drive shaft will transfer torque to the lower drive shaft at the same angular speed.
Patent NZ-586050-A (NZ)
Title: An apparatus for detecting movement of a utility meter and generating an alarm
Inventor: MURPHY MICHAEL A
IPC: G01D4/02
Filed: 2008-12-23
Abstract: 586050 Disclosed is a tamper alarm circuit (215) for detecting a tampered condition of a utility meter. The tamper alarm circuit (215) is comprised of a transducer (Ctran), an amplification circuit (320) and a comparator circuit (325). The transducer (Ctran) generates a transducer output in response to physical movement of the utility meter. The amplification circuit (320) receives and amplifies the transducer output and generates an amplified output. The comparator circuit (325) receives the amplified output, compares the amplified output to a predetermined threshold that corresponds to a tampering condition, and provides a comparator output (Vout) when the amplified output exceeds the predetermined threshold.
Patent NZ-586385-A (NZ)
Title: Method for lyophilising particles having a pharmaceutical compound contained therein by heating a bed of the particles
Inventor: MIDDELBEEK HANS ALMER
IPC: A61K9/19
Filed: 2009-01-20
Abstract: Disclosed is a method for lyophilising particles (30) comprising frozen liquid having a pharmaceutical compound contained therein. A heat conducting container (15, 15') having a bottom and side walls is filled with a bed (29) of the particles, the bed comprising multiple layers of the particles and having an aspect ratio (ratio of the width of the bed to its height) of not less than 1. A heat source (5a-c) is located above a top layer of the particles, the heat source having a surface directed to a top layer of the bed, the surface having an emissivity coefficient of at least 0.4. The particles filled in the container are subjected to a reduced pressure. At least the bottom of the container and the surface are heated to provide heat to the particles to support sublimation of the frozen liquid at the reduced pressure, and after the frozen liquid is sublimated, stopping the provision of heat to the particles. The invention also includes to a pharmaceutical pack comprising a container having contained therein at least one particle obtained via this method.
Patent NZ-587388-A (NZ)
Title: A lock where rotation of the handle when deadlocked does not transfer the force of rotation to the latch
Inventor: SULLIVAN KEVIN FRANCIS
IPC: E05B13/08
Filed: 2010-08-16
Abstract: A lock with a deadlocking member or lock plate is disclosed. The deadlocking member is movable to a position where a formation of a drive component of a mechanism of the lock contacts the lock plate or a formation thereon, so that drive component is prevented from being pivoted further. In an exemplary embodiment the lock (10A) which includes a lock body (12A) having a stop member (84), a main latch tongue (14Z) which is mounted to the lock body (12A) and which is movable to an extended position and a deadlocking member (16A) having an abutment shoulder (136) and a fulcrum point. The deadlocking member (16A) is movable to a deadlocked position at which the abutment shoulder (136) of the abuts the stop member (84) and limits movement of the main latch tongue (14Z) from the extended position. Additionally a drive component (20A) operates to cause the main latch tongue (14Z) to move from the extended position so that when the deadlocking member (16A) is moved to the deadlocked position, operation of the drive component causes at least a part of the drive component (20A) to abut the deadlocking member (16A) causing rotation of the deadlocking member about the fulcrum point and forcing the abutment shoulder (136) of the of the deadlocking member against the stop member (84).
Patent NZ-589457-A (NZ)
Title: Method and apparatus for the fair sharing of resources in a wireless network
Inventor: CHAKRABARTI ARNAB
IPC: H04W88/04
Filed: 2009-03-06
Abstract: 589457 Disclosed is a method and system for sharing resources in a wireless network. The method includes employing a communication interface to obtain a network service request from a wireless apparatus and employing one or more data processors to execute shared resource management instructions for the wireless apparatus. The instructions cause the data processors to determine whether the wireless apparatus is associated with a resource sharing subscription and initialize an amount of credits for the wireless apparatus upon obtaining the network service request. The initializing is conditioned upon determining the resource sharing subscription the amount of credits is updated when the wireless apparatus relinquishes a wireless channel resource to, or employs a wireless channel resource relinquished by, a disparate wireless node.
Patent NZ-591500-A (NZ)
Title: A toy block unit having 50 faces and a toy block game set consisted of toy blocks made therefrom
Inventor: CHENG MING-HSIEN
IPC: A63H33/06
Filed: 2011-03-02
Abstract: A toy block of a toy blocks game set, comprises fifty adjacent faces arranged in seven layers, where the first layer 1 includes a single horizontal hexagonal face on top of the block, a subjacent second layer 2 includes six adjacent pentagonal faces, a subjacent third layer 3 includes twelve adjacent pentagonal faces set in six symmetrical pairs, a subjacent fourth layer 4 includes twelve adjacent pentagonal faces, a subjacent fifth layer 5 includes twelve adjacent pentagonal faces set in six symmetrical pairs arranged symmetrically with the faces of the third layer, a subjacent sixth layer 6 includes six adjacent pentagonal faces arranged symmetrically with the faces of the second layer are symmetrical, and a seventh layer 7 includes a single horizontal hexagonal face provided on the bottom of the block.
Patent NZ-594290-A (NZ)
Title: Pyranose derived pesticidal compositions
Inventor: CROUSE GARY
IPC: A01N43/16
Filed: 2010-02-11
Abstract: The disclosure is directed to compounds of Formula (I) and their use as pesticides. Ar1 and Ar2 are aryl or heterocyclic rings; E is N, C, or CR5; G is a double or triple bond; M is N, C, or CR5; J is O, N, NR5, CR5, or C=O; L is a single or double bond; K is CR5, C=O, N, NR5, or C=S; R1-5 are hydrogen, halogen, oxo, alkyl, haloalkyl, haloalkoxy, alkenyloxy, alkyl substituted with O-alkyl and amines substituted with hydrocarbon or hydrogen as given in the disclosure. The application of these compounds to a locus inhabited by pests, to genetically transformed seeds or plants and orally to a non-human animal. Examples of compounds of Formula (I) are [4-( 4-Trifluoromethoxy -phenylazo)-phenyl ]-carbamic acid (2S ,3R ,4R ,5S ,6S)-4-ethoxy-3,5-dimethoxy-6-methyl-tetrahydropyran-2-yl ester and [4-(3-trifluoromethoxyphenylazo)-phenyl]-carbamic acid (2S ,3R ,4R ,5S ,6S)-3,5-dimethoxy -4-ethoxy -6-methyl-tetrahydropyran -2-yl ester.
Patent NZ-594937-A (NZ)
Title: Beloxepin, its enantiomers, and analogs thereof for the treatment of pain
Inventor: LE BOURDONNEC BERTRAND
IPC: C07H17/08
Filed: 2009-02-19
Abstract: Disclosed is beloxepin enriched in the (-) enantiomer for treating pain, depression, obsessive-compulsive disorder, anorexia nervosa, bulimia nervosa, trichotilomania, insomnia related to opioid withdrawal, and attention deficit hyperactivity disorder and pre-menstral syndrome or dysphoria and fibromyalgia.